We are excited to announce CannMed 2020’s Keynote Presenter in the Cultivation Focus Area, and our guest on the latest Coffee Talk Podcast, is Seth Crawford, PhD. Dr. Crawford is the owner and co-founder of Oregon CBD, along with his brother, Eric. Together (and with the help of some 41 scientists, geneticists and breeders) they specialize in turning out new, …
Testing Cannabis Products with Ini Afia
In this episode we get the chance to talk with our first representative from the Safety Focus Area. Ini Afia is the Scientific Director at CannaSafe Labs, one of the largest cannabis testing labs in California. If you aren’t familiar with what exactly goes on at a cannabis testing lab, you are likely in the majority. The cannabis testing labs …
Cannabis Medicine for Children with Bonni Goldstein, MD
We are excited to announce Bonni S. Goldstein, MD as the CannMed 2020’s Keynote Presenter in the Medicine Focus Area. The title of Dr. Goldstein’s presentation is “Cannabis Medicine for Children.” She will be sharing her latest clinical findings, including promising results from her clinical practice focusing on the use of phytocannabinoid medicines to treat serious pediatric medical condition, including …
Cannabis and COVID-19 with Martin A. Lee
In this episode of CannMed Coffee Talk we talk with Martin A. Lee, the co-founder and director of Project CBD. In addition to creating content for the Project CBD website and speaking at conferences around the globe, Martin has authored several books, including Smoke Signals: A Social History of Marijuana–Medical, Recreational and Scientific. In fact, we have a copy in our Medicinal …
The Endocannabinoid System 101 with Ethan Russo, MD
We are excited to announce CannMed 2020’s Keynote Presenter in the Science Focus Area is Dr. Ethan Russo. The title of Dr. Russo’s presentation is “Cannabis and Psychiatry: The Final Frontier”, and it will explore basic science and clinical trial data to assess the role of cannabis psychopharmacology with respect to issues of impairment, depression, insomnia, PTSD, schizophrenia, anxiety and …
Assembling a Better Cannabis Reference Genome with Kevin McKernan
We have a great episode for you today featuring Medicinal Genomics Chief Scientific Officer Kevin McKernan. Kevin is a legend in the genomic sequencing space going back to his days working on the human genome project. He has applied his experience and knowledge to trying to better understand the cannabis genome, which as he mentions in the episode is one …
Welcome to the CannMed Coffee Talk Podcast
Medicinal Genomics invites you to listen to our new CannMed Coffee Talk Podcast. Each episode we talk with the leading minds in cannabis science, medicine, cultivation, and safety testing, discussing topics from the bench to the bedside. Don’t miss this opportunity to get a sneak-peek into the 4 FOCUS AREAS that will be covered at CannMed 2020 in Pasadena, CA on September 20-22, 2020.
CannMed 2020 Registration Now Open!
It’s happening! 214 days until #CannMed2020! Join Medicinal Genomics and 60+ presenters in Pasadena, CA on September 20-22. Our 24,840 square foot exhibit hall will be filled with 50+ industry leading sponsors, exhibitors, and advocacy groups showcasing the greatest minds in cannabis science, medicine, cultivation, and safety. CannMed was born to promote understanding of cannabis’ complex science and its medical benefits …
How Analytical Testing Can Help Optimize Cannabis as a Medicine
Many parts of the world have used cannabis as a medicine for thousands of years, but we have only truly begun to understand the mechanisms by which cannabis provides relief in the last century. Much of the evidence currently available is anecdotal or preclinical, which is insufficient for demonstrating true efficacy in humans. Furthermore, while we now have a decent …
The State of Cannabis Testing – Incongruence and Unknowns
As cannabis gains wider acceptance in the mainstream there is an ever growing need to ensure that consumers are receiving quality product with known potency that is free of contaminants. At present there are 33 states in the US that have legalized cannabis for medicinal use and 11 for recreational use. In this nascent industry, many aspects of how to …